Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immediate vs. Deferred ART in MSM and Transgender Women with Early HIV (SABES?)
NCT01815580Phase 4Completed
- Sponsor
- Fred Hutchinson Cancer Center
- Start
- Jul 2013
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tenofovir disoproxil fumarate, emtricitabine + elvitegravir + cobicistat + tenofovir disoproxil in human immunodeficiency virus infection (HIV), sponsored by Fred Hutchinson Cancer Center. Started Jul 2013; status: completed.
02
Drugs
tenofovir disoproxil fumarateemtricitabine + elvitegravir + cobicistat + tenofovir disoproxil
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01815580.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01815580.